Schedule 13D ownership disclosure
Juno Therapeutics, Inc.
Security class unavailable · CUSIP: 48205A109
Event date: 2015-06-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001571049-15-005529
- Form type
- SC 13D
- Filer
- Celgene Rivot Ltd
- CIK
- CIK 1646600
- Filed
- Jul 08, 2015
- Reporting period
- Jun 29, 2015
- Description
- Schedule 13D beneficial ownership